Pioglitazone lowered plasma insulin ( P < @ ) , improved insulin sensitivity ( P < @ ) , increased HDL ( P < @ ) , and reduced triglycerides ( P = @ ) , free fatty acids ( P = @ ) , and C-reactive protein ( P = @ ) .